JMJared M. McLendon

Jared M. McLendon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jared M. McLendon has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular Significance of Sorbs2 in Alzheimer’s Disease

    by Grace Rocco, Henry Lin, Ryan L Boudreau, Jared M McLendon

    Background: Sorbs2 is a cytoskeletal adaptor protein that is expressed in hippocampal neurons, but its mechanistic role in these cells is not yet fully understood.Method: We created two groups of mice for our study: whole‐body Sorbs2‐Knockout (KO) mice and Sorbs2‐Flox mice, which had neuronal knockout via AAV‐PHP.eB‐hSyn1‐Cre virus injection. We assayed mixed‐sex littermate cohorts at 6 months of age (n = 24 each, WT/KO; n = 8 each ± CRE) with behavior tests. We used postmortem brain samples to visualize and quantify Sorbs2 expression and microtubule stability.Result: Our preliminary results suggest that female Sorbs2‐KO mice have a decrease in freezing time during contextual fear conditioning at 6 months of age. We next tested an independent cohort of females (n = 8v8) and the data show reduced freezing time in cued fear conditioning and decreased interaction time with the displaced object in Spatial Object Recognition tests after 24 hours. From the above‐mentioned experiments, we have collected tissue samples for molecular and histological analysis. Preliminary results show that global Sorbs2‐KO mice have a complete loss of an immunoreactive band specific to neuronal Sorbs2 isoform at ∼150 kDa, whereas AAV‐Cre injected Sorbs2‐flox mice have > 50% reduction in neuronal Sorbs2. In preliminary studies, we assessed microtubule stability in hippocampus homogenates from global Sorbs2‐KO or WT mice and showed an increase in the amount of free tubulin and a decrease in the amount of polymerized tubulin in the knockout samples. These data suggest that loss of Sorbs2 may destabilize microtubules in the hippocampus.Conclusion: Our results suggest that Sorbs2 may regulate microtubule stability in the brain and be involved in memory formation or retrieval. In future studies, we plan to identify populations of Sorbs2‐expressing cells in the brain, interrogate neuronal‐specific Sorbs2 deletion, and assess the intersection between Sorbs2 and AD‐related phenotypes in mouse models of neurodegeneration.


  • Open Access

    Modulation of the Cardiac Sodium Channel Na V 1.5 Peak and Late Currents by NAD + Precursors

    by Daniel S. Matasic, Jin-Young Yoon, Jared M. McLendon, Haider Mehdi, Mark S. Schmidt, Alexander M. Greiner, Pravda Quinones, Gina M. Morgan, Ryan L. Boudreau, Kaikobad Irani, et al.

    Rationale: The cardiac sodium channel Na V 1.5, encoded by SCN5A , produces the rapidly inactivating depolarizing current I Na that is responsible for the initiation and propagation of the cardiac action potential. Acquired and inherited dysfunction of Na V 1.5 results in either decreased peak I Na or increased residual late I Na (I Na,L ), leading to tachy/bradyarrhythmias and sudden cardiac death. Previous studies have shown that increased cellular NAD + and NAD + /NADH ratio increase I Na through suppression of mitochondrial reactive oxygen species and PKC-mediated Na V 1.5 phosphorylation. In addition, NAD + -dependent deacetylation of Na V 1.5 at K1479 by Sirtuin 1 increases Na V 1.5 membrane trafficking and I Na . The role of NAD + precursors in modulating I Na remains unknown. Objective: To determine whether and by which mechanisms the NAD + precursors nicotinamide riboside (NR) and nicotinamide (NAM) affect peak I Na and I Na,L in vitro and cardiac electrophysiology in vivo . Methods and Results: The effects of NAD + precursors on the NAD + metabolome and electrophysiology were studied using HEK293 cells expressing wild-type and mutant Na V 1.5, rat neonatal cardiomyocytes (RNCMs), and mice. NR increased I Na in HEK293 cells expressing Na V 1.5 (500 μM: 51 ± 18%, p=0.02, 5 mM: 59 ± 22%, p=0.03) and RNCMs (500 µM: 60 ± 26%, p=0.02, 5 mM: 75 ± 39%, p=0.03) while reducing I Na,L at the higher concentration (RNCMs, 5 mM: −45 ± 11%, p=0.04). NR (5 mM) decreased Na V 1.5 K1479 acetylation but increased I Na in HEK293 cells expressing a mutant form of Na V 1.5 with disruption of the acetylation site (Na V 1.5-K1479A). Disruption of the PKC phosphorylation site abolished the effect of NR on I Na . Furthermore, NAM (5 mM) had no effect on I Na in RNCMs or in HEK293 cells expressing wild-type Na V 1.5, but increased I Na in HEK293 cells expressing Na V 1.5-K1479A. Dietary supplementation with NR for 10-12 weeks decreased QTc in C57BL/6J mice (0.35% NR: −4.9 ± 2.0%, p=0.26; 1.0% NR: −9.5 ± 2.8%, p=0.01). Conclusions: NAD + precursors differentially regulate Na V 1.5 via multiple mechanisms. NR increases I Na , decreases I Na,L , and warrants further investigation as a potential therapy for arrhythmic disorders caused by Na V 1.5 deficiency and/or dysfunction.